Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

eVariant

Explore full profile

Combines digital marketing, big data, and analytics into one platform for healthcare providers to improve patient engagement and physician alignment

Farmington, United StatesFounded 2008Biotech & Life Sciences
Valuation $100–250M Last recorded · 2015
Headcount <100 Current team size
Total funding $50–100M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for eVariant and the history behind them.

About eVariant

eVariant operated as a healthcare technology company focused on patient and physician engagement, founded in 2008 by Bill Moschella and Rob Grant. The firm established its niche by providing a cloud-based platform that integrated customer relationship management (CRM), marketing automation, and data analytics specifically for hospitals and healthcare systems. Its primary clients were hospital marketers and physician relations teams at mid-to-large-sized hospital networks across the United States. The company's business model was centered on its 'Patients for Life Platform,' a Software-as-a-Service (SaaS) solution designed to help healthcare providers acquire and retain high-value patients. This was achieved by enabling clients to launch targeted marketing campaigns and providing real-time data on physician referral streams, which allowed for precise analysis of marketing return on investment.

Read full description

The platform's core function was to consolidate consumer, patient, provider, and claims data, and then apply proprietary analytics to yield actionable intelligence. This allowed healthcare systems to identify, guide, and maintain relationships with desired patient demographics and physicians. Key features included a healthcare-specific CRM, a physician relationship management (PRM) tool, and applications for call centers. A significant aspect of the platform was its ability to integrate with a hospital's existing clinical, billing, and other information systems. One of the platform's key selling points was its alignment with Salesforce, leveraging the latter's growing dominance in the enterprise healthcare market. Over its lifetime, eVariant raised approximately $98.8 million in funding from investors including Lightspeed Venture Partners, Goldman Sachs, and McKesson Ventures.

A major milestone in the company's history was its acquisition by Healthgrades in January 2020. The acquisition aimed to create a comprehensive, end-to-end engagement platform for a combined customer base of over 2,000 hospitals and life sciences clients. The merger combined eVariant's CRM and data analytics capabilities with Healthgrades' consumer-facing website and marketing services, offering a more scaled and integrated solution for health systems navigating industry consolidation. Following the transaction, eVariant shareholders retained a minority stake in the newly combined entity.

Source: Dealroom company data

At a glance

Status
Acquired
Founded
2008
Headquarters
Farmington, United States
Employees
24
Open positions
None listed
Dealroom signal
61.7/100
Industry
Health, Enterprise Software
Sub-industry
BioTechnology, Health Platform
Sector
Biotech & Life Sciences, Analytics, Data Analytics, CRM, Predictive Analytics, Biotechnology, Patient Care, Hard Tech, DT and LS, science-based
Business model
SaaS

Funding history

8 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
ACQUISITIONOther financing Jan 2020 $0 — Health Grades —
SERIES COther financing Feb 2018 — — Goldman Sachs · Salesforce · McKesson Ventures —
Showing the latest 2 of 8 recorded eventsBook a demo for the full funding history →

Growth signals

eVariant website traffic

Latest recorded traffic for eVariant is 410 monthly website visits, up 156.3% over the last three months. eVariant's team grew 0% over the past year.

Latest monthly visits410 3-month web change+156.3% 1-year team growth0%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Investors

7 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A3 investors entered at this stage

Series B and later3 investors entered at this stage

Other known investors1 additional known investor

  • Health Grades
Team profiled 28 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 4 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇺🇸 United States100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about eVariant on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See eVariant’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.